Skip to Main Content
Who We Are
Back
Overview
Mission
Board
Medical Advisory Committee
Research Advisory Committee
Program Committee
Staff
Founders
Funding Partners
Blood Disorders
News
Join Us
Back
Membership Overview
Events
Newsletter
Education
Back
Overview
Archived Webinars, Symposia, and Workshops
Case Conversation Series
Learning Module: Clinical Strategies for Managing HMB
Curricula
FWGBD Biennial Conference
Upcoming Symposia
Resources
Back
7-2-1 Podcast
Animations
Ask-the-Experts
Autoimmune Hemolytic Anemia (AIHA) Resource Center
Clinics
Genetics
Guidelines, Screening Tools & Recommendations
Immune Thrombocytopenia Resources
Provider Handouts
Patient Resources
Period Talk Toolkit
Resource Library
Networks
Back
WGBD® Clinics of Excellence
LAN Overview
Current WGBD® LAN Members
Current WGSCD™ LAN Members
Research & Workforce Development
Back
Workforce Overview
Research Fellowship Awards
FWGBD Research Grant Award
FWGBD Annual Research Grant Awards
FWGBD Special Research Grant Awards
Past Award Winners
Search
youtube
Donate
Rilzabrutinib, an oral Bruton tyrosine kinase inhibitor, in patients with warm autoimmune haemolytic anaemia: a prospective, single-arm, multicentre, phase 2b safety and clinical activity study (LUMINA 2)